CMS received an external request to add ICD-9-CM V58.83, Encounter for therapeutic drug monitoring, as a covered indication for the Prothrombin Time (PT) NCD at 190.17 of the NCD manual.
We are seeking public comment on the addition of code V58.83 to the ICD-9-CM Codes Covered By Medicare list for the PT NCD.
The regulation for maintaining code lists in the negotiated NCDs for clinical diagnostic laboratory services states that codes on the covered list flow from the existing NCD narratives of covered indication. The regulation was published February 25, 2005 in the Federal Register, Vol.70, No. 37 and can be viewed at http://www.cms.hhs.gov/CoverageGenInfo/04_LabNCDs.asp#TopOfPage.
July 24, 2006
CMS accepts a request to add ICD-9-CM code V58.83.0 as a covered indication in the Prothrombin Time national coverage determination list of covered indications.
The initial 30-day public comment period begins with this acceptance date, and ends after 30 calendar days. CMS considers all public comments, and is particularly interested in clinical studies and other scientific information relevant to the test under consideration.
